Atrovent

Section 8 - MEDICATION GUIDELINES

BRONCHODILATORS

Ipatropium Bromide (ATROVENT) / Bronchodilator

DESCRIPTION

• Inhibits interaction of acetylcholine at receptor sites on the bronchial smooth muscle, resulting in decreased cGMP and bronchodilation.

INDICATIONS

• For the treatment of bronchospasm associated with chronic pulmonary disease, including asthma, bronchitis, and emphysema.

CONTRAINDICATIONS

• Hypersensitivity to Ipratropium Bromide, or to atropine and its derivatives. Not for use in CHF or cardiac asthma.

PRECAUTIONS

• Use with caution in patients with narrow angle glaucoma, prostatic hypertrophy or bladder neck obstruction.

DOSAGE

• 0.5 mg updraft AND refer to appropriate PRACTICE PARAMETER for specific dosage.